Latest Desmopressin Stories
SAN FRANCISCO, December 7, 2014 /PRNewswire/ -- Today, Novo Nordisk announced a new analysis of phase 3 data demonstrating people with haemophilia A who had the highest
PARSIPPANY, N.J., Oct. 22, 2014 /PRNewswire-USNewswire/ -- Ferring Pharmaceuticals is pleased to announce that the company has acquired DDAVP® (desmopressin acetate) from Sanofi.
- Only Hemophilia A Therapy to Provide Bleeding Protection with Prophylactic Regimens of Either Every Three to Five Days or Once-Weekly Infusions - MISSISSAUGA, ON, Aug.
LOS ANGELES, July 10, 2014 /PRNewswire/ -- Sleep Apnea Doctors US aims to help doctors find patients in their local
LOS ANGELES, June 13, 2014 /PRNewswire/ -- Sleep Apnea Doctors US is now looking to assist doctors in finding local
- Kogenate® FS antihemophilic factor (recombinant) approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A WHIPPANY,
- Three-year commitment of up to 20 million units per year of blood clotting medicines to treat hemophilia patients in developing countries BARCELONA, Spain, April 17, 2014 /PRNewswire/
Inspirational video is launched on World Hemophilia Day to tell the story of one Canadian's triumph over adversity TORONTO, April 17, 2014 /CNW/ - Attitude makes you a hero;
6.9 million people have a bleeding disorder.
The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 Years CAMBRIDGE, MA, March 24, 2014 /CNW/ -